Overview

* Cryo-Cell ( CCEL ) fiscal Q3 revenue decreased 3% yr/yr to $7.83 mln

* The cord blood bank firm's net income for fiscal Q3 fell to $749,000 from $1.05 mln yr/yr

Outlook

* Company did not provide specific guidance for future quarters or the full year in the press release

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $7.83

Revenue mln

Analyst Coverage

* The one available analyst rating on the shares is "buy"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy"

* Wall Street's median 12-month price target for Cryo-Cell International Inc ( CCEL ) is $8.50, about 41.2% above its May 16 closing price of $5.00

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)